A Counterfeit Drug Manufacturer is an entity or individual involved in the illegal production and distribution of fake or unauthorized pharmaceutical products. These counterfeit drugs often mimic legitimate medications but may contain incorrect or harmful ingredients, incorrect dosages, or no active ingredients at all. The production and sale of counterfeit drugs pose significant risks to public health and safety, as they can lead to ineffective treatment, adverse health effects, and increased resistance to genuine medications. Counterfeit Drug Manufacturers operate covertly, often exploiting weaknesses in regulatory systems and supply chains to distribute their products.
Main/
Counterfeit Drug Manufacturer
[]
Code
AT0105
[]
Name
Counterfeit Drug Manufacturer
[]
Version
1.0
[]
Category
Criminal & Illicit Networks
[]
Created
2025-03-15
[]
Modified
2025-04-02
Related Techniques
Counterfeit drug manufacturers derive illegal income from producing and distributing unauthorized pharmaceuticals.
- Funnel proceeds through various channels, including bank and non-bank accounts, to obscure their origin.
- May use shell or front companies to legitimize profits from the sale of fake medications.
Counterfeit drug manufacturers produce or repackage falsified pharmaceuticals for illicit distribution. By operating outside regulated supply chains and misrepresenting substandard ingredients, they accumulate proceeds that require laundering. Their activities include:
- Sourcing cheap or unregulated materials in jurisdictions with minimal enforcement.
- Directing online distribution channels that obscure true product quality and authenticity from end buyers, undermining financial institutions’ ability to detect illicit revenue sources.